The Leadership Team at Healx drives the strategic vision and operational excellence necessary to transform drug discovery for rare diseases. Comprising executives from diverse backgrounds in artificial intelligence, collaboration, science, and business development, the team fosters innovation and guides the development of novel therapeutics, ensuring alignment with the company’s mission to improve patient outcomes globally.
Andrew Watson
VP, Artificial Intelligence
Bruce Bloom
Chief Collaboration Officer
David Brown
Co-Founder & Chairman
Eugenia Wachters
VP, Commercial & Operations
Laura Fink
VP, People
Mark Youssef
Global Head, Business Developm...
Neil Thompson
Chief Scientific Officer
Ryan Tomlinson
VP, Engineering
Tim Guilliams
Co-Founder & CEO
View all